Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $0.0748 $0.0748 Friday, 10th May 2024 BLCM stock ended at $0.0748. During the day the stock fluctuated 0% from a day low at $0.0748 to a day high of $0.0748.
90 days $0.0701 $0.104
52 weeks $0.0600 $0.85

Historical Bellicum Pharmaceuticals prices

Date Open High Low Close Volume
Jan 04, 2017 $13.97 $14.71 $13.97 $14.56 313 175
Jan 03, 2017 $13.87 $14.10 $13.53 $13.89 268 489
Dec 30, 2016 $13.93 $14.15 $13.56 $13.62 337 940
Dec 29, 2016 $14.08 $14.27 $13.70 $13.93 202 725
Dec 28, 2016 $14.40 $14.60 $13.95 $14.05 184 148
Dec 27, 2016 $14.62 $15.17 $14.48 $14.50 246 927
Dec 23, 2016 $13.59 $14.85 $13.59 $14.61 290 215
Dec 22, 2016 $13.98 $14.12 $13.50 $13.62 224 014
Dec 21, 2016 $14.31 $14.31 $13.60 $13.96 397 239
Dec 20, 2016 $14.83 $14.89 $14.04 $14.38 384 962
Dec 19, 2016 $15.44 $15.57 $14.65 $14.73 276 090
Dec 16, 2016 $15.66 $15.82 $15.05 $15.41 364 698
Dec 15, 2016 $15.80 $16.10 $15.23 $15.63 415 547
Dec 14, 2016 $16.16 $16.20 $15.51 $15.80 321 868
Dec 13, 2016 $15.95 $16.44 $15.94 $16.12 216 218
Dec 12, 2016 $16.00 $16.15 $15.83 $15.89 254 041
Dec 09, 2016 $16.74 $17.00 $16.02 $16.05 361 951
Dec 08, 2016 $16.57 $16.72 $16.00 $16.59 374 896
Dec 07, 2016 $16.90 $17.16 $16.03 $16.56 662 333
Dec 06, 2016 $18.11 $18.11 $16.95 $17.27 647 228
Dec 05, 2016 $20.00 $20.19 $17.77 $18.27 1 029 483
Dec 02, 2016 $16.89 $18.89 $16.75 $18.72 723 834
Dec 01, 2016 $18.52 $18.70 $16.68 $16.98 591 065
Nov 30, 2016 $19.73 $19.73 $17.86 $17.93 451 527
Nov 29, 2016 $18.96 $19.82 $18.55 $19.16 356 879
Click to get the best stock tips daily for free!

About Bellicum Pharmaceuticals

Bellicum Pharmaceuticals Bellicum Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally. The company's clinical product candidates include BPX-601, an autologous GoCAR-T product candidate, which is in Phase 1/2 clinical trials for the treatment of solid tumors expressing the prostate stem ce... BLCM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT